Insiders Cytosorbents Corporation

Equities

CTSO

US23283X2062

Market Closed - Nasdaq Other stock markets 04:00:00 2024-05-31 pm EDT			5-day change	1st Jan Change
0.9001 ^USD	+2.28%		+0.01%	-18.91%

May. 09	Earnings Flash (CTSO) CYTOSORBENTS Posts Q1 Revenue $9.8M, vs. Street Est of $9.79M	MT
May. 09	Transcript : Cytosorbents Corporation, Q1 2024 Earnings Call, May 09, 2024

Insiders

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Cytosorbents Reappoints Kathleen Bloch as Finance Chief	23-09-19	MT
Cytosorbents Corporation Announces Appointment of Kathleen Bloch as Full-Time CFO	23-09-18	CI
Cytosorbents Reports Resignation of CFO D'Amico	23-09-01	MT
Cytosorbents Corporation Announces Resignation of Alexander D?Amico as Chief Financial Officer, Effective August 28, 2023	23-09-01	CI
Cytosorbents Names Alexander D'Amico CFO	23-07-19	MT
CytoSorbents Corporation Appoints Alexander D'Amico as Chief Financial Officer	23-07-19	CI
CytoSorbents Completes Enrollment of the STAR-T Pivotal Trial	23-07-07	CI
Cytosorbents Corporation Announces Retirement of Al W. Kraus as A Member of Board	23-04-20	CI
Cytosorbents Corporation Appoints Irina B. Kulinets as Senior Vice President of Global Regulatory Affairs	23-01-17	CI
Cytosorbents Chief Financial Officer Kathleen Bloch to Retire in March	22-10-07	MT
Cytosorbents Corporation Hires Shaun Whittemore as Country Manager - UK & Ireland	22-04-14	CI
Cytosorbents Corporation Appoints Jiny Kim to its Board of Directors	22-04-05	CI
CytoSorbents Corporation Appoints Terri Anne Powers as Vice President of Investor Relations and Corporate Communications	21-06-01	CI
Cytosorbents Corporation Appoints James Komsa as Vice President – U.S. Sales and Marketing	21-05-05	CI
Cytosorbents Corporation Appoints David D. Cox, Ph.D., M.B.A. as Vice President - Global Regulatory Affairs	21-01-21	CI
CytoSorbents Promotes Dr. Christian Steiner to Executive Vice President of Sales and Marketing	20-12-17	CI
CytoSorbents Promotes Vincent J. Capponi to President and COO	20-05-04	CI
CytoSorbents Corporation Appoints Efthymios N. Deliargyris as Chief Medical Officer, Effective on May 1, 2020	20-04-27	CI
Cytosorbents Corporation Announces Resignation of Eric Mortensen as Chief Medical Officer, Effective December 31, 2019	19-12-12	CI
Eric Mortensen, Chief Medical Officer, to Leave Cytosorbents Corporation	19-11-06	CI

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Insiders Cytosorbents Corporation

Equities

CTSO

US23283X2062

Insiders

Filters